Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
B cells shape naive CD8+ T cell programming
Cameron Manes, … , Ross M. Kedl, Jared Klarquist
Cameron Manes, … , Ross M. Kedl, Jared Klarquist
Published April 17, 2025
Citation Information: J Clin Invest. 2025;135(12):e190106. https://doi.org/10.1172/JCI190106.
View: Text | PDF
Research Article Autoimmunity Immunology

B cells shape naive CD8+ T cell programming

  • Text
  • PDF
Abstract

The presence of B cells is essential for the formation of CD8+ T cell memory after infection and vaccination. In this study, we investigated whether B cells influence the programming of naive CD8+ T cells prior to their involvement in an immune response. RNA sequencing indicated that B cells are necessary for sustaining the FOXO1-controlled transcriptional program, which is critical for homeostasis of these T cells. Without an appropriate B cell repertoire, mouse naive CD8+ T cells exhibit a terminal, effector-skewed phenotype, which significantly impacts their response to vaccination. A similar effector-skewed phenotype with reduced FOXO1 expression was observed in naive CD8+ T cells from human patients undergoing B cell–depleting therapies. Furthermore, we show that patients without B cells have a defect in generating long-lived CD8+ T cell memory following COVID vaccination. In summary, we demonstrate that B cells promote the quiescence of naive CD8+ T cells, poising them to become memory cells upon vaccination.

Authors

Cameron Manes, Miguel Guerrero Moreno, Jennifer Cimons, Marc A. D’Antonio, Tonya M. Brunetti, Michael G. Harbell, Sean Selva, Christopher Mizenko, Tyler L. Borko, Erika L. Lasda, Jay R. Hesselberth, Elena W.Y. Hsieh, Michael R. Verneris, Amanda L. Piquet, Laurent Gapin, Ross M. Kedl, Jared Klarquist

×

Figure 3

Naive CD8+ T cells from B cell–restricted hosts exhibit normal proliferative capacity, but defective survival.

Options: View larger image (or click on image) Download as PowerPoint
Naive CD8+ T cells from B cell–restricted hosts exhibit normal prolifera...
(A) Purified CD8+ T cells were plated with or without 5 ng/mL human IL-7. Ratio of cells surviving to number of cells plated is displayed over time. Data are combined from 3 experiments. Analysis by 2-way ANOVA yielded a significant interaction effect, indicating that the slopes of the two lines differ significantly. (B–D) Purified CD8+ T cells from WT and MD4 mice were dye-labeled, mixed in equal numbers, and cotransferred into WT or MD4 mice. (B) Experimental schematic. (C) Ratio of transferred cells in blood 2 hours after transfer, and in spleens 7 days later. (D) CD127 and CD122 gMFI was analyzed on transferred cells and endogenous naive CD8+ T cells on day 7. (E) Purified CD8+ T cells from WT or MD4 mice were stimulated with plate-bound anti-CD3. Representative proliferation dye dilution (top) and proliferation index (bottom). (F–I) Purified OT1 T cells from WT or MD4 mice were dye-labeled, mixed in equal numbers, and transferred into sublethally irradiated recipients. Spleens were analyzed 10 days later. (F) Experimental schematic. (G) Representative proliferation dye dilution as percentage of maximum (left) or as total counts (right). (H and I) Proliferation (H) and expansion (I) indices. (J–M) Purified OT1 T cells from WT and MD4 mice were mixed in equal numbers and transferred to recipient mice, which then received subunit vaccination. (J) Experimental schematic. (K) Ratio of transferred OT1 T cells at day 3. (L) Representative EdU incorporation plots. (M) Quantification of EdU incorporation. Data shown are means ± SEM, representative of ≥2 experiments. Significance was defined by 2-way ANOVA with Holm-Šidák multiple-comparison test; *P < 0.05, **P < 0.01, ***P < 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts